Search in:

Ocular Immunology and Inflammation Volume 31, 2023 - Issue 6: COVID-19 and the Eye

Submit an article Journal homepage

Free access

339

Views

CrossRef citations to date

Altmetric

Listen

Editorial

From the Editors

Ilknur Tugal-Tutkuna The Department of Ophthalmology, Istanbul University, Istanbul, Turkey;b Eye Protection Foundation Bayrampasa Eye Hospital, Istanbul, TurkeyCorrespondence[email protected]

https://orcid.org/0000-0002-4020-453X

, MD

Derrick P. Smitc The Division of Ophthalmology, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa

https://orcid.org/0000-0003-3206-8184

, MBChB, MMed, FCOphth, PhD

Emmett T. Cunninghamd The Department of Ophthalmology, California Pacific Medical Center, San Francisco, California, USA;e The Department of Ophthalmology, Stanford University School of Medicine, Stanford, California, USA;f The Francis I. Proctor Foundation, UCSF School of Medicine, San Francisco, California, USA

, Jr, MD, PhD, MPH &

Jennifer E. Thorneg The Department of Ophthalmology, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA;h The Department of Epidemiology, The Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland, USA

, MD, PhD

Pages 1115-1116 | Published online: 31 Jul 2023

Cite this article
https://doi.org/10.1080/09273948.2023.2226027
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Reprints & Permissions
View PDF PDF View EPUB EPUB

In the first COVID−19 editorial published in Ocular Immunology and Inflammation (OII) in 2021, it was expected that our understanding of the ocular complications of both acute and chronic infection would be better defined and expanded in the following months and years.^Citation1 In a subsequent COVID−19 editorial published in 2022, which includedh 20 articles that reported ocular complications, clinicians were encouraged because ocular complications tended to be both mild to moderate and readily reversible with corticosteroids.^Citation2

In this special issue of OII, we included 40 new articles covering COVID 19, mostly reporting ocular inflammation presumed to be caused by the infection,^{Citation3–9} opportunistic infections,^{Citation10–12} choroidal and retinal microvascular changes during COVID−19 or following recovery from COVID−19 infection,^{Citation13–15} and ocular complications following administration of various COVID−19 vaccines.^{Citation16–39} We hope that these additional reports will shed more light on possible and presumptive complications of both COVID−19 infection and immunization.

Disclosure statement

No potential conflict of interest was reported by the author(s).

References

Cunningham ET Jr, Zierhut M.SARS-CoV-2, COVID-19, and the Eye. Ocul Immunol Inflamm. May 19, 2021;29(4):629–630. doi:10.1080/09273948.2021.1970423.
PubMed Web of Science ®Google Scholar
Cunningham ET Jr, Moorthy RS, Agarwal M, Smit DP, Zierhut M. Ocular complications following COVID-19 vaccination - coincidence, correlation, or causation? Ocul Immunol Inflamm. July, 2022;30(5):1031–1034. doi:10.1080/09273948.2022.2125763.
PubMed Web of Science ®Google Scholar
Ozdemir Yalcinsoy K, Ozdamar Erol Y, Ozdal PC. Bilateral granulomatous panuveitis in a patient with COVID-19. Ocul Immunol Inflamm. 2023;31(6): 1206–1209. doi:10.1080/09273948.2022.2061523.
PubMed Web of Science ®Google Scholar
Vienne-Jumeau A, Brézin AP, Debieb A. Bilateral anterior uveitis following paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 - case report and focused review. Ocul Immunol Inflamm. 2023;31(6): 1265–1269. doi:10.1080/09273948.2022.2143381.
PubMed Web of Science ®Google Scholar
Kılıçarslan O, Yılmaz Çebi A, Uçar D, Şentürk F, Aras C. Bilateral cystoid macular Edema after COVID-19: 1 year follow up. Ocul Immunol Inflamm. 2023;31(6): 1236–1239. doi:10.1080/09273948.2022.2114916.
Web of Science ®Google Scholar
Ayachit A, Joshi M, Ayachit G, Joshi S, Shah P-P-P-C. Presumed post-COVID infection retinitis - clinical and tomographic features of retinitis as a post-COVID syndrome. Ocul Immunol Inflamm. 2023;31(6): 1117–1121. doi:10.1080/09273948.2022.2060264.
Web of Science ®Google Scholar
Patnaik G, Arunkumar WV, Lagvankar M. Bilateral Acute Depigmentation of Iris (BADI) post COVID infection following systemic moxifloxacin therapy. Ocul Immunol Inflamm. 2023;31(6): 1210–1212. doi:10.1080/09273948.2022.2069126.
PubMed Web of Science ®Google Scholar
Altan C, Basarir B, Bayraktar S, Tugal-Tutkun I. Bilateral Acute Depigmentation of Iris (BADI) and Bilateral Acute Iris Transillumination (BAIT)following acute COVID-19 infection. Ocul Immunol Inflamm. 2023;31(6): 1163–1168. doi:10.1080/09273948.2022.2103832.
Web of Science ®Google Scholar
Niedzwiecka E, San Miguel MP C, Gonzalez Herrera M, Sánchez Rodriguez-Acosta I. Bilateral Acute Depigmentation of the Iris (BADI) following Covid-19 infection. Ocul Immunol Inflamm. 2023;31(6): 1230–1231. doi:10.1080/09273948.2022.2113801.
Web of Science ®Google Scholar
Tehrani S, Fekri S, Demirci H, et al. Coincidence of candida endophthalmitis, and aspergillus and Pneumocystis jirovecii pneumonia in a COVID-19 patient: case report. Ocul Immunol Inflamm. 2023;31(6): 1291–1294. doi:10.1080/09273948.2023.2188224.
PubMed Web of Science ®Google Scholar
Markan A, Dogra M, Katoch D, Tomar M, Mittal H, Singh R. Endogenous endophthalmitis in COVID-19 patients: a case series and literature review. Ocul Immunol Inflamm. 2023;31(6): 1191–1197. doi:10.1080/09273948.2023.2192273.
Web of Science ®Google Scholar
Manoharan A, Agarwal A, Dutta Majumder P. Acute retinal necrosis: a covid-19 perspective. Ocul Immunol Inflamm. 2023;31(6): 1270–1272. doi:10.1080/09273948.2022.2159842.
Web of Science ®Google Scholar
Shrivastav A, Zhou WS, Ng S, et al. Choroidal microvascular alterations in COVID-19 patients. Ocul Immunol Inflamm. 2023;31(6): 1122–1127. doi:10.1080/09273948.2022.2062387.
Web of Science ®Google Scholar
Nageeb Louz RE, Salah Eddin MA, Macky TA, Tolba DAA. Post COVID-19 retinal evaluation using optical coherence tomography angiography: a case control study. Ocul Immunol Inflamm. 2023;31(6): 1175–1183. doi:10.1080/09273948.2022.2141651.
Web of Science ®Google Scholar
Uzun S, Uzun F. Analysis of microvasculature in children recovered from COVID-19 using swept-source OCT/OCTA technology. Ocul Immunol Inflamm. 2023;31(6): 1310. doi:10.1080/09273948.2022.2094813.
Web of Science ®Google Scholar
Habot-Wilner Z, Neri P, Okada AA, et al. COVID vaccine-associated uveitis. Ocul Immunol Inflamm. 2023;31(6): 1198–1205. doi:10.1080/09273948.2023.2200858.
Web of Science ®Google Scholar
Ren J, Zhang T, Li X, Liu G. Ocular inflammatory reactions following an inactivated SARS-CoV-2 vaccine: a four case series. Ocul Immunol Inflamm. 2023;31(6): 1128–1133. doi:10.1080/09273948.2022.2093754.
Web of Science ®Google Scholar
Cho SK, Wu XN, Amaratunge C. Acute uveitis following AstraZeneca COVID-19 vaccination. Ocul Immunol Inflamm. 2023;31(6): 1295–1298. doi:10.1080/09273948.2023.2189456.
PubMedGoogle Scholar
Bellur S, Zeleny A, Patronas M, Jiramongkolchai K, Kodati S. Bilateral acute macular neuroretinopathy after COVID-19 vaccination and infection. Ocul Immunol Inflamm. 2023;31(6): 1222–1225. doi:10.1080/09273948.2022.2093753.
PubMed Web of Science ®Google Scholar
Bleicher ID, Brill D, Wu F, Sobrin L, Patel N. Acute idiopathic maculopathy following SARS-CoV-2 vaccination. Ocul Immunol Inflamm. 2023;31(6): 1232–1235. doi:10.1080/09273948.2022.2114915.
Web of Science ®Google Scholar
Gargouri MA, Yousfi N, Toutain J, et al. Multiple evanescent white dot syndrome following COVID-19 mRNA vaccination. Ocul Immunol Inflamm. 2023;31(6): 1240–1244. doi:10.1080/09273948.2022.2127782.
PubMed Web of Science ®Google Scholar
Baharani A, Reddy RR. Multiple evanescent white dot syndrome following adenovirus vector-based COVID-19 vaccine (Covishield). Ocul Immunol Inflamm. 2023;31(6): 1299–1304. doi:10.1080/09273948.2023.2192271.
Web of Science ®Google Scholar
Shen C, Tennant M. Unilateral acute idiopathic blind spot enlargement following second dose of Covid-19 mRNA vaccine. Ocul Immunol Inflamm. 2023;31(6): 1219–1221. doi:10.1080/09273948.2022.2090964.
Web of Science ®Google Scholar
Chean CS, Ali E, Kulkarni P, Kapoor B, Kumar P. Bilateral persistent placoid maculopathy following COVID-19 vaccines: real or coincidence? Ocul Immunol Inflamm. 2023;31(6): 1273–1278. doi:10.1080/09273948.2023.2170889.
PubMed Web of Science ®Google Scholar
Yi Z, Chen L, Zheng H, Chen C. Retinal vasculitis following COVID-19 vaccination: causation or coincidence? Ocul Immunol Inflamm. 2023;31(6): 1283–1285. doi:10.1080/09273948.2023.2176887.
PubMed Web of Science ®Google Scholar
Mohamed S, Chan CK, Tsang CW, et al. Case report: retinal vasculitis in two adolescents after COVID-19 vaccination. Ocul Immunol Inflamm. 2023;31(6): 1245–1249. doi:10.1080/09273948.2022.2129694.
Web of Science ®Google Scholar
Chandrasekaran PR. A curious case of occlusive retinal vasculitis in a young individual associated with COVID-19 vaccination. Ocul Immunol Inflamm. 2023;31(6): 1254–1260. doi:10.1080/09273948.2022.2137046.
Web of Science ®Google Scholar
Takacs A, Ecsedy M, Nagy ZZ. Possible COVID-19 MRNA vaccine-induced case of unilateral central retinal vein occlusion. Ocul Immunol Inflamm. 2023;31(6): 1145–1150. doi:10.1080/09273948.2022.2094811.
Web of Science ®Google Scholar
Shah PP, Glidai Y, Braunstein R, et al. Reports of new and recurrent keratitis following mRNA-based COVID-19 vaccination. Ocul Immunol Inflamm. 2023;31(6): 1169–1174. doi:10.1080/09273948.2022.2133730.
Web of Science ®Google Scholar
Cohen S, Olshaker H, Fischer N, et al. Herpetic Eye disease following the SARS-CoV-2 vaccinations. Ocul Immunol Inflamm. 2023;31(6): 1151–1162. doi:10.1080/09273948.2022.2103831.
Web of Science ®Google Scholar
Marziali E, Pasqualetti R, Bacci G, de Libero C, Caputo R. Acute rejection following COVID-19 vaccination in penetrating keratoplasty in a Young Male - a case report and review of literature. Ocul Immunol Inflamm. 2023;31(6): 1226–1229. doi:10.1080/09273948.2022.2106248.
Web of Science ®Google Scholar
Sanjay S, Handa A, Kawali A, Shetty R, Bhakti Mishra S, Mahendradas P. Scleritis and episcleritis following coronavirus disease (COVID-19) vaccination. Ocul Immunol Inflamm. 2023;31(6): 1184–1190. doi:10.1080/09273948.2023.2182324.
Web of Science ®Google Scholar
de Queiroz Tavares Ferreira F, Araújo DC, de Albuquerque LM, Bianchini PM, Holanda EC, Pugliesi A. Possible association between Vogt-Koyanagi-Harada disease and coronavirus disease vaccine: a report of four cases. Ocul Immunol Inflamm. 2023;31(6): 1134–1140. doi:10.1080/09273948.2022.2093756.
Web of Science ®Google Scholar
Shirah B, Mulla I, Aladdin Y. Optic neuritis following the BNT162b2 mRNA COVID-19 vaccine in a patient with systemic lupus erythematosus uncovering the diagnosis of neuromyelitis optica spectrum disorders. Ocul Immunol Inflamm. 2023;31(6): 1213–1215. doi:10.1080/09273948.2022.2089901.
Web of Science ®Google Scholar
Saluja P, Kohli GM, More A, Shetty SB, Sen A. Bilateral atypical optic neuritis following ChAdOx1_nCoV-19 vaccination: a putative plausibility. Ocul Immunol Inflamm. 2023;31(6):1250–1253. doi:10.1080/09273948.2022.2137044.
Web of Science ®Google Scholar
Yoshida N, Tsukada A. A case of neuroretinitis following COVID-19 vaccination. Ocul Immunol Inflamm. 2023;31(6): 1261–1264. doi:10.1080/09273948.2022.2137047.
Google Scholar
Nair GS, Khan IA, Rizvi SWA, Shahid S. A case of neuroretinitis following inactivated virion COVID-19 vaccination. Ocul Immunol Inflamm. 2023;31(6): 1279–1282. doi:10.1080/09273948.2023.2173244.
Google Scholar
Hung CW, Hung CH. Reactivation of graves’ disease and thyroid Eye disease following COVID-19 vaccination - a case report. Ocul Immunol Inflamm. 2023;31(6): 1286–1290. doi:10.1080/09273948.2023.2176889.
Google Scholar
Yucel Gencoglu A, Mangan MS. Orbital inflammatory pseudotumor following mRNA COVID-19 vaccination. Ocul Immunol Inflamm. 2023;31(6): 1141–1144. doi:10.1080/09273948.2022.2093757.
Google Scholar

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Download PDF

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Your download is now in progress and you may close this window

Did you know that with a free Taylor & Francis Online account you can gain access to the following benefits?

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Have an account?
Login now Don't have an account?
Register for free

Login or register to access this feature

Have an account?
Login now Don't have an account?
Register for free

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

From the Editors

Disclosure statement

References

Information for

Open access

Opportunities

Help and information

From the Editors

Disclosure statement

References

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Your download is now in progress and you may close this window

Login or register to access this feature

Information for

Open access

Opportunities

Help and information

Keep up to date